• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Medtech Insight and Windhover Information's 2006 ``Investment in Innovation (In3) Europe: A Preview of Emerging Medical Technologies''; International Biotech Investing, Business Development the Focus of Premier Informational & Networking Event

Posted on: Monday, 21 August 2006, 12:00 CDT

September 18-20, 2006 Crowne Plaza, Brussels City Centre, Belgium

The 2006 "Investment in Innovation (In3) Europe: A Preview of Emerging Technologies," sponsored by Medtech Insight, a division of Windhover Information, has set a groundbreaking agenda for the Sept. 18-20 conference.

In3 Europe is the industry's most efficient strategic partnering and investment meeting for the international medtech development community. The audience will be comprised of hundreds of senior-level decision-makers from most of the major medtech companies and healthcare investment firms worldwide, representing most of the major dealmakers in the medical technology industry.

Dynamic agenda planned for conference

In addition to its premier opportunities for networking and partnering throughout the event, In3 Europe will feature a number of eminent healthcare executives as speakers and an in-depth industry panel discussion. The agenda includes:

-- "Best Practices for Venture Investing in Europe" with Michel Lussier, CEO of MedPole, Chairman of Cardio3 and VP & General Manager of European Operations for Volcano

-- "Medtech Investing in Europe: the 3i Perspective" with Andrew Fraser, Partner, 3i

-- "The European Route: First CE-mark and then FDA approval; does it make sense?" with Dirk Meijer, M.D., Ph.D., CEO, Factory CRO

-- "What Makes Israel Such a Dynamic Device Company Developer?" with Zev Zehavi, Johnson & Johnson Development Corporation, and David Cassak, Managing Partner, Windhover Information, as moderator

Lussier founded MedPole SA/NV in March 2002, a European incubator for medical device start-up companies. During its first years of operation, MedPole has enabled the early European development of a number of US, Israeli, and European high-technology medical device companies, including Cardio3 SA, a start-up cell therapy company dedicated to cell transplant solutions for cardiovascular applications.

Fraser has 12 years of experience in venture capital in life sciences, and specializes in investing in medical devices and pharmaceuticals companies. Notable recent investments include Endosense, Novexel and Carmel Pharma.

Dr. Meijer has more than 15 years of experience in the design of clinical trials and analysis of European regulatory affairs for medical devices, and has published numerous articles in medical journals and has given many presentations to professional societies.

More than 50 companies to present

Emerging medical technology companies from around the world seeking funding, acquisition and/or strategic partnership opportunities are schedule to present at the conference. The current list of presenters includes:

-- ABMI, Lausanne, Switzerland -- expert systems and miniaturized hardware for stroke prevention and management and for pre-operative brain protection

-- AION Diagnostics, Perth, Australia -- diagnostic applications for BioSilicon platform technology

-- Arbel Medical, Yokneam, Israel --technological platform for the next generation of minimally invasive cryosurgical treatments

-- BioImagene, Cupertino, CA -- analyze, search, store, mine, share and unlock the power of digital tissue images

-- Biosan Medical, Rishon Le'Zion, Israel -- surgical device/method for the treatment of stroke/subarachnoid and intraventricular hemorrhages of different etiologies

-- Card Guard Scientific Survival, Rehovot, Israel -- embedded medical and wellness applications in wireless and cellular platforms

-- Cardio3, Braine L'Alleud, Belgium -- a process for stem cell selective differentiation and transplantation in heart failure patients

-- Cheetah Medical, Ra'anana, Israel -- NICOM(TM), a continuous, noninvasive hemodynamic monitoring that delivers accurate results, sensor placement flexibility, and motion tolerance

-- Diagnostic Devices, Simsbury, CT -- accurate and efficient identification of human Embryonic Stem Cell using Signal Characteristic Analysis (hE(SC)2AN)

-- Dialog Devices, Leicestershire, UK - PADD for noninvasive screening of peripheral vascular disease, combining postural and infrared blood volume testing

-- EMcision, London, UK -- medical devices utilizing radiofrequency and microwave energy which are cost-effective and clinically relevant

-- Innovate, Manchester, UK -- flexible safety system protecting healthcare workers from needle-stick injury, allowing separated disposal of sharps/waste

-- InspireMD, Tel Aviv, Israel -- a micron level sleeve which wraps stents to seamlessly block embolic showers without affecting deliverability

-- Lapeyre Industries, Eysines, France - technology description available soon

-- LiverCyte, London, UK -- technology for the manipulation of adult stem cells to repopulate chronically diseased liver tissue

-- Morris Innovative Research, Bloomington, IN - vascular access sheath with pre-mounted re-absorbable closure device

-- Novashunt, Saratoga, CA -- automated implantable pump systems for moving fluids around inside the body

-- OZ Recovery Technologies, Ramat Gan, Israel -- a medical device for wound therapy using controlled ozone and oxygen mixtures

-- PreSRV, Yokneam, Israel -- an implant preserving the femoral head and cartilage in patients with displaced femoral neck fractures

-- Protomed, Marseille, France -- minimally invasive instruments and implants to improve outcomes of laparoscopic vascular surgery

-- Provista Life Sciences, Phoenix, AZ -- noninvasive diagnostic technologies for the early detection of estrogen associated cancers and Alzheimer's disease

-- Stentys, Paris, France -- bifurcated coronary stent

-- SutureAid, Andover, MA -- technology description available soon

-- Tibion, Moffett Field, CA -- active orthotic devices - programmable, sensor-driven muscle assistance, resistance, and robotic therapy for the mobility impaired

-- Triage Medical, Irvine, CA -- minimally invasive dynamic stabilization device

-- Victhom Human Bionics, Quebec, Canada -- Implantable Closed Loop System device (neuromodulation, neurosensing, neurostimulation), restoring gait for lost mobility (i.e. stroke patients)

-- WideMed, Herzliya, Israel -- disease management system for early detection of heart failure using a noninvasive cardiovascular-sleep prognostic marker

The forum will provide focused overviews by a senior executive from each presenting company, followed by the opportunity to meet one-on-one in private breakout rooms.

Co-sponsors for In3 Europe include 3i, Battelle, Business Wire, Factory, Medical Capital Advisers, Ronald Trahan Associates and T for G.

Registrations now being accepted

Windhover is now accepting registrations for the event, which will be held Sept. 18-20 in Brussels, Belgium.

Medtech Insight's conferences have drawn over 6,100 attendees and 700 innovative early-stage presenting companies over the past five years. Participating companies send multiple attendees, including company presidents, CEOs, partners, and VPs for business development, marketing, acquisitions, corporate development and R&D.

Past attending companies have included 3M, AG Edwards, Arthur Andersen, Bayer, Boston Scientific, The Cleveland Clinic Foundation, C.R. Bard, Cordis, Edwards Lifesciences, Eli Lilly, Ernst & Young, FibroGen, Glaxo Smith Kline, The Gray Sheet, Guidant, Hologic Inc., Integra Life Sciences. Johnson & Johnson, Karolinska Investment Fund, Kimberly-Clark, Krauth Medical, Massachusetts Institute of Technology, Medtronic, Morgan Stanley, NASDAQ, Novartis, Procter & Gamble, Smith & Nephew, Stryker, Tenex, Yale University School of Medicine, and ZEVEX International.

To register, call Kristy Grimes of Medtech Insight at 480-985-9512, or 888-202-5939 toll-free in the U.S.; e-mail kristy@medtechinsight.com; or register on the In3 Medical Device Summit website at www.meddevicesummit.com.

About Medtech Insight

Medtech Insight, a division of Windhover Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace. For more on the company's products and services, please see www.medtechinsight.com.

Source: Business Wire

More News in this Category